 Cortexyme, Inc. Nasdaq: CRTX today announced that its work to pioneer upstream therapeutic approaches to improve the lives of patients diagnosed with Alzheimers and other degenerative diseases will be the subject of three research abstracts at the Alzheimers Association International Conference 2020 AAIC. The largest international meeting dedicated to advancing dementia science, AAIC will be held as a virtual event this year from July 27-31, 2020. 